Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1120152]Brief description Lung diseases (emphysema, severe asthma & pulmonary fibrosis) are major burdens on Australian community and economy. Airway wounding is a key feature of all these diseases. Patients experience severe breathlessness seriously impacting quality of life and frequently leading to death. We will assess the potential of a new target (IL-33), & therapy (anti-IL-33) in suppressing wounding in experimental models and human tissues. This may lead to a new treatment to reverse and/or prevent lung diseases.
Funding Amount $AUD 326,131.75
Funding Scheme Early Career Fellowships
Notes Peter Doherty Biomedical ECF
- nhmrc : 1120152
- PURL : https://purl.org/au-research/grants/nhmrc/1120152
